|
Table 37.3. FIGO staging of cervical cancer. |
|
Designation |
Definition |
|
Stage 0 |
Carcinoma in situ |
|
Stage I |
Cancer confined to the cervix (corpus extension is disregarded) |
|
IA |
Preclinical cancer, i.e., diagnosed by microscopy only |
|
IA1 |
Measured depth of stromal invasion no greater than 3.0 mm |
|
IA2 |
Microscopically measurable lesion with depth of invasion <5 mm and horizontal spread <7 mm |
|
IB |
Clinical lesions confined to the cervix or preclinical lesions greater than stage IA2 |
|
IB1 |
Clinical lesions no greater than 4.0 cm in size |
|
IB2 |
Clinical lesions greater than 4.0 cm in size |
|
Stage II |
Parametrial extension, but not to the sidewall; involvement of the upper two-thirds of the vagina |
|
IIA |
No evidence of parametrial involvement |
|
IIB |
Obvious parametrial extension |
|
Stage III |
Extension of cancer to the pelvic sidewall or lower one-third of the vagina; hydronephrosis or nonfunctioning kidney secondary to cancer |
|
IIIA |
No pelvic sidewall extension |
|
IIIB |
Extension to the sidewall and/or hydronephrosis or nonfunctioning kidney |
|
Stage IV |
Spread beyond the reproductive tract |
|
IVA |
Infiltration of bladder or rectal mucosa |
|
IVB |
Metastases to distant organs or disease outside the true pelvis |